IL1B and systemic lupus erythematosus: AIM2‐like receptors, including IFN‐inducible protein 16 and AIM2, are gaining increasing attention in SLE due to the significant pathogenic role of IFN in lupus and the positive association between disease activity in SLE and inflammasome‐induced production of IL‐1β.33, 34